Atypical course of type 1 diabetes mellitus in a patient with Ollier's disease - a case report
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.013Keywords
diabetes mellitus, Ollier’s disease, diabetologyAbstract
Background
Nowadays, we can distinguish more than two types of diabetes mellitus. Due to blood glucose measurement and genetic tests, different types of diabetes (such as autoimmune, monogenetic, atypical) can be detected. Despite the constantly updated recommendations and the progress of diagnostic tests, making a diagnosis may be difficult.
Case report
A 23-year old patient was admitted to the Department of Endocrinology due to diagnosed diabetes mellitus to determine its primary cause. Elevated blood glucose level was identified during periodic medical test and was confirmed by OGTT test. In the patient’s medical history: Ollier’s disease with multiple enchondromas, treated surgically in childhood, no typical symptoms and risk factors of hyperglycaemia.
During hospitalization the laboratory tests showed decreased level of C-peptide, nevertheless the patient represented acceptable levels of glycaemia following only by diet restriction. MODY, LADA and diabetes due to Ollier’s disease was speculated. Due to suspicion of autoimmunological cause the diagnostic was extended by testing antibodies: IAA, IA2, GAD, IC, which confirmation allowed to recognise untypical diabetes mellitus type 1.
The patient objected to insulin treatment, limited it only to a diet and maintained normoglycemia for 15months. However, after an increase in glycaemia and in HbA1c, insulin therapy was introduced.
Disscussion with conclusion
Atypical course of diabetes should be considered in patients with a known disorder or with comorbidities associated with diabetes and without typical symptoms of hyperglycaemia. Atypical forms of diabetes are uncommon and require etiology-specific therapies.
References
International Diabetes Federation, ‘IDF Diabetes Atlas 2021. 10th ed. International Diabetes Federation’, Brussels 2021, accessed 30 May 2022, https://diabetesatlas.org/atlas/tenth-edition.
Elliott TL, and Pfotenhauer KM, ’Classification and Diagnosis of Diabetes’, Primary Care: Clinics in Office Practice, Volume 49, Issue 2, 1 June 2022, p. 191-200, https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0095454321016419?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0095454321016419%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F.
Thong EP, Catford S, Fletcher J, Wong P, Fuller PJ, Teede H, and Milat F, ‘Recurrent vertebral fractures in a young adult: a closer look at bone health in type 1 diabetes mellitus’, Endocrinology, Diabetes & Metabolism Case Reports, Volume 2018, Issue 1, 10 May 2018, https://doi.org/10.1530/EDM-18-0010.
Grant SFA, Hakonarson H, and Schwartz S, ‘Can the Genetics of Type 1 and Type 2 Diabetes Shed Light on the Genetics of Latent Autoimmune Diabetes in Adults?’, Endocrine Reviews, Volume 31, Issue 2, 1 April 2010, p. 183–193, https://doi.org/10.1210/er.2009-0029.
Østergaard JA, Laugesen E, and Leslie RD, ‘Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies’, Current Diabetes Reports, Volume 16, Issue 9, 25 July 2016, https://doi.org/10.1007/s11892-016-0780-0.
Broome DT, Pantalone KM, Kashyap SR, and Philipson LH, ‘Approach to the Patient with MODY-Monogenic Diabetes’, The Journal of Clinical Endocrinology & Metabolism, The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 1, 9 October 2020, p. 237–250, https://doi.org/10.1210/clinem/dgaa710.
Colclough K, and Patel K, ‘How Do I Diagnose Maturity Onset Diabetes of the Young in My Patients?’, Clinical Endocrinology, 20 April 2022, p. 1-12, https://doi.org/10.1111/cen.14744.
Harris A, Letourneau LR, and Greeley SAW, ‘Monogenic Diabetes: The Impact of Making the Right Diagnosis’, Current Opinion in Pediatrics, Volume 30, Issue 4, August 2018, p. 558-567, https://doi.org/10.1097/MOP.0000000000000643.
Bro S, and Olgaard K, ‘Effects of Excess PTH on Nonclassical Target Organs’, American Journal of Kidney, Volume 30, Issue 5, 1 November 1997, p. 606-620, https://doi.org/10.1016/S0272-6386(97)90484-4.
Carlsson S, ‘Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes’, Frontiers in Physiology, Volume 10, Issue 320, 26 March 2019, https://doi.org/10.3389/fphys.2019.00320.
Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD, ‘Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel’, Diabetes, Volume 69, Issue 10, 1 October 2020, p. 2037–2047, https://doi.org/10.2337/dbi20-0017.
Maddaloni E, Moretti C, Mignogna C, Buzzetti R, ‘Adult-onset autoimmune diabetes in 2020: An update’, Maturitas, Volume 137, Issue 3, 30 April 2020, p. 37-44, https://doi.org/10.1016/j.maturitas.2020.04.014.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Anna Kochanowska, Kinga Knop, Zuzanna Piasecka, Maria Kowalczuk, Grzegorz Rudzki
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 386
Number of citations: 0